Investors

 

Investor Relations

 

At Viro-Gen, our commitment is to empower humanity with the tools for safe and effective disease management. We have deployed some of the finest scientists in Virology, Biochemistry and Immunology to develop the world’s first isotekh, an immune system optimisation treatment. With the ever-growing threat to humanity of disease outbreaks, it is our mission at Viro-Gen to bring a solution to the world that is natural and based on the human body’s own intelligent design.

This mission has been supported by Johannesburg Stock Exchange-listed pharmaceutical, Adcock Ingram (www.adcock.com), that has supported Viro-Gen’s early-stage discovery.

The following milestones mark important value events in our development timeline:

Workstream

Location

Study Phase

Completion

CANCER

Brazil

Animal

Q1 2024

DIABETES

South Africa

Animal

Q4 2024

HIV

South Africa

Animal

Q1 2025

The completion of pre-clinical work and establishment of the efficacy-safety profile of Viro-Gen’s isotekh-platform will yield an unmatched reward to forward-looking investors. 

Comparative Market Exits

 

The table below illustrates a small sample of Pre-clinical early stage exits on promising immune system technologies in the biotech marketplace

Acquirer

Target

Deal Date

Technology

Ticket Size

Novo Nordisk

Dicerna Pharmaceuticals
2021
RNA gene inhibitor. Technology mutes the function of certain disease causing genes

$3,3 bn

Novartis

IFM Therapeutics
2019
Interleukin Inhibitor. Technology inhibits inflammation causing interleukin proteins

$1,6 bn

IPO (Nasdaq)

Sana Biotechnology
2021
Cell engineering. Technology engineers cells as medicines and therapies for Diabetes I & Parkinsons disease

$676 mn

Viro-Gen has opened an A-series investment window to qualifying investors who espouse the values of putting humanity before profits.

To get more information on how to invest, contact us at info@viro-gen.com.

Our Address

PMA House, Block B, Ground Floor,
Tijger Vallei Office Park, Silver Lakes Road,
Silver Lakes, Pretoria, 0081

    Contact Us

Tel No: +27 (0)87 092 5148
Email:  info@viro-gen.com